Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Aug 2:4:e95.
doi: 10.14309/crj.2017.95. eCollection 2017.

A Fatal Case of Erdheim-Chester Disease with Hepatic Involvement

Affiliations
Case Reports

A Fatal Case of Erdheim-Chester Disease with Hepatic Involvement

Gokulakrishnan Balasubramanian et al. ACG Case Rep J. .

Abstract

Erdheim-Chester disease (ECD) is a rare form of systemic histiocytosis, typically presenting with striking osseous involvement characterized by bilateral osteosclerosis and involvement of organs such as the lung, pituitary gland, heart, and brain. Liver involvement with ECD is extremely uncommon. We report a 56-year-old woman presenting with newly diagnosed cirrhosis and signs concerning for intra-abdominal malignancy, including omental caking and peritoneal thickening. Liver biopsy demonstrated xanthogranulomatous infiltration from ECD. The patient showed initial improvement with interferon therapy, but she developed severe depression, which led to the discontinuation of the treatment. Shortly afterward, she died from progressive liver dysfunction resulting in hepatorenal syndrome.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Abdominal computed tomography showing peritoneal carcinomatosis, including omental caking (arrows), scattered peritoneal nodularity, and ascites.
Figure 2
Figure 2
Erdheim-Chester disease histology. (A) Hematoxylin and eosin (H&E) stain of the liver biopsy showing hepatic parenchyma infiltrated by pale histiocytes (100x). (B) High magnification of H&E stain showing foamy histiocytes (arrow) (400x). (C) Trichrome stain showing cirrhosis characterized by extensive bridging fibrosis and nodular formation (100x). (D) H&E section of peritoneal biopsy showing similar foamy histiocytes (black arrow) and a Touton giant cell (blue arrow) (400x).
Figure 3
Figure 3
Immunohistochemical stains on liver biopsy. (A) CD163 showing numerous positive histiocytes filling the liver sinusoids (100x). (B) CD68 showing positivity in the histiocytes (100x). (C) Factor XIIIa showing weak to strong positivity in the histiocytes (100x). (D) CD1a is negative in the histiocytes (100x).

References

    1. Chester W. Uber lipoidgranulomatose. Virchows Arch Pathol Anat. 1930;279:561–602.
    1. Cavalli G, Guglielmi B, Berti A, et al. . The multifaceted clinical presentations and manifestations of Erdheim-Chester disease: Comprehensive review of the literature and of 10 new cases. Ann Rheum Dis. 2013;72:1691–5. - PubMed
    1. Diamond EL, Dagna L, Hyman DM, et al. . Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124:483–92. - PMC - PubMed
    1. Arnaud L, Hervier B, Néel A, et al. . CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: A multicenter survival analysis of 53 patients. Blood. 2011;117:2778–82. - PubMed
    1. Haroche J, Arnaud L, Cohen-Aubart F, et al. . Erdheim-Chester disease. Rheum Dis Clin North Am. 2013;39:299–311. - PubMed

Publication types

LinkOut - more resources